A detailed history of Ubs Group Ag transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 26,529 shares of ALDX stock, worth $127,073. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,529
Previous 48,026 44.76%
Holding current value
$127,073
Previous $158,000 10.13%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.19 - $6.32 $68,575 - $135,861
-21,497 Reduced 44.76%
26,529 $142,000
Q2 2024

Aug 13, 2024

SELL
$3.25 - $4.72 $942 - $1,368
-290 Reduced 0.6%
48,026 $158,000
Q1 2024

May 13, 2024

SELL
$2.77 - $4.22 $13,187 - $20,091
-4,761 Reduced 8.97%
48,316 $157,000
Q4 2023

Feb 09, 2024

SELL
$1.47 - $6.06 $31,631 - $130,399
-21,518 Reduced 28.85%
53,077 $186,000
Q3 2023

Nov 09, 2023

SELL
$6.11 - $8.16 $89,413 - $119,413
-14,634 Reduced 16.4%
74,595 $498,000
Q2 2023

Aug 11, 2023

BUY
$7.11 - $11.89 $588,857 - $984,741
82,821 Added 1292.46%
89,229 $748,000
Q1 2023

May 12, 2023

BUY
$5.77 - $9.93 $26,588 - $45,757
4,608 Added 256.0%
6,408 $63,000
Q4 2022

Feb 08, 2023

SELL
$5.08 - $7.09 $121,935 - $170,181
-24,003 Reduced 93.02%
1,800 $12,000
Q3 2022

Nov 10, 2022

SELL
$3.8 - $7.74 $2.79 Million - $5.69 Million
-734,694 Reduced 96.61%
25,803 $138,000
Q2 2022

Aug 10, 2022

SELL
$2.43 - $4.85 $485,747 - $969,495
-199,896 Reduced 20.81%
760,497 $3.04 Million
Q1 2022

May 16, 2022

BUY
$3.25 - $5.17 $2.52 Million - $4.01 Million
776,593 Added 422.52%
960,393 $4.27 Million
Q4 2021

Feb 14, 2022

BUY
$3.5 - $9.63 $163,159 - $448,921
46,617 Added 33.98%
183,800 $735,000
Q3 2021

Nov 15, 2021

BUY
$7.94 - $11.31 $971,117 - $1.38 Million
122,307 Added 822.18%
137,183 $1.21 Million
Q2 2021

Aug 13, 2021

SELL
$10.44 - $14.85 $355,283 - $505,360
-34,031 Reduced 69.58%
14,876 $168,000
Q1 2021

May 12, 2021

SELL
$6.53 - $14.42 $349,178 - $771,080
-53,473 Reduced 52.23%
48,907 $581,000
Q4 2020

Feb 11, 2021

SELL
$6.31 - $8.13 $23,100 - $29,763
-3,661 Reduced 3.45%
102,380 $702,000
Q3 2020

Nov 12, 2020

BUY
$4.0 - $7.53 $411,292 - $774,257
102,823 Added 3195.25%
106,041 $785,000
Q2 2020

Jul 31, 2020

SELL
$1.97 - $5.05 $23,513 - $60,276
-11,936 Reduced 78.76%
3,218 $14,000
Q1 2020

May 01, 2020

SELL
$1.62 - $6.4 $42,957 - $169,708
-26,517 Reduced 63.63%
15,154 $37,000
Q4 2019

Feb 14, 2020

BUY
$4.73 - $7.98 $78,423 - $132,308
16,580 Added 66.08%
41,671 $242,000
Q3 2019

Nov 14, 2019

BUY
$4.41 - $6.12 $69,744 - $96,787
15,815 Added 170.49%
25,091 $132,000
Q2 2019

Aug 14, 2019

SELL
$6.0 - $9.0 $21,486 - $32,229
-3,581 Reduced 27.85%
9,276 $56,000
Q1 2019

May 14, 2019

BUY
$7.14 - $9.85 $999 - $1,379
140 Added 1.1%
12,857 $116,000
Q4 2018

Feb 14, 2019

BUY
$7.26 - $13.29 $10,541 - $19,297
1,452 Added 12.89%
12,717 $106,000
Q3 2018

Nov 14, 2018

BUY
$6.8 - $14.35 $27,941 - $58,964
4,109 Added 57.42%
11,265 $155,000
Q2 2018

Aug 14, 2018

BUY
$6.95 - $9.18 $4,969 - $6,563
715 Added 11.1%
7,156 $57,000
Q1 2018

May 15, 2018

BUY
$6.55 - $8.9 $29,579 - $40,192
4,516 Added 234.6%
6,441 $48,000
Q4 2017

Feb 14, 2018

BUY
$5.7 - $7.75 $3,767 - $5,122
661 Added 52.29%
1,925 $13,000
Q3 2017

Nov 14, 2017

BUY
$3.9 - $10.8 $608 - $1,684
156 Added 14.08%
1,264 $9,000
Q2 2017

Aug 14, 2017

SELL
N/A
-721 Reduced 39.42%
1,108 $5,000
Q1 2017

Nov 14, 2017

BUY
N/A
1,829
1,829 $9,000

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $279M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.